Caskey Davis S Insider Trades

Insider Trading History

Track insider trading activity for Caskey Davis S. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Elite Pharmaceuticals
Elite Pharmaceuticals ELTP
Director
Holding Value $820k 2,049,436 shares
Last Trade
Nov 22, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$84k 547,657 shares
$0.15
$0.40
Elite Pharmaceuticals
Elite Pharmaceuticals ELTP
Director
Holding Value $601k 1,501,779 shares
Last Trade
Aug 28, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$18.4k 459,536 shares
$0.04
$0.40
Elite Pharmaceuticals
Elite Pharmaceuticals ELTP
Director
Holding Value $417k 1,042,243 shares
Last Trade
Jun 30, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$14.8k 295,570 shares
$0.05
$0.40
Elite Pharmaceuticals
Elite Pharmaceuticals ELTP
Director
Holding Value $299k 746,673 shares
Last Trade
Aug 20, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$33.6k 516,781 shares
$0.06
$0.40
Elite Pharmaceuticals
Elite Pharmaceuticals ELTP
Director
Holding Value $91.9k 229,892 shares
Last Trade
Feb 26, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$16.7k 161,374 shares
$0.10
$0.40
Elite Pharmaceuticals
Elite Pharmaceuticals ELTP
Director
Holding Value $27.4k 68,518 shares
Last Trade
Feb 23, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$9.18k 68,518 shares
$0.13
$0.40

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up